In the June 11 COVID-19 update from The Saskatchewan Health Authority they are reporting 81 new cases of the virus in the province.

Of those 81 new cases there are 3 in the Far North West zone, 4 in the Far North East zone, 13 in the North West zone, 7 in the North Central zone, 3 in the North East zone, 17 in the Saskatoon zone, 3 in the Central East zone, 14 in the Regina zone, 7 in the South Central zone, and 2 in the South East zone.

There are 7 new cases in the South West zone - 1 in the South West subzone 1, and 6 in the South West subzone 2.

There is 1 case with pending residence information.

One case with pending residence information has been assigned to the Central East zone.

Fifteen cases tested out of the province were added as follows - 9 to the Far North East zone, 1 to the Far North West zone, 1 to the North East zone, 3 to the Saskatoon zone, and 1 to the South East zone.

That brings the provincial total number of cases to 47,764, of which 899 are considered active.

There are 14 active cases in t he South West zone - 6 in the South West subzone 1, and 8 in the South West subzone 2.

The seven-day average of new COVID-19 cases is 78 (6.4 new cases per 100,000 population).

There are 98 recoveries reported, bringing that provincial total to 46,311.

There is 1 new death reported today in the 80+ age group from the Saskatoon zone.

That brings the provincial total number of deaths to 554.

There are 104 people in the hospital. Eighty-seven people are receiving inpatient care, including 1 patient from Manitoba - 13 in the North West zone, 5 in the North Central zone, 30 in the Saskatoon zone, 4 in the Central East zone, 28 in the Regina zone, 5 in the South Central zone, and 1 in the South East zone.

There is 1 person receiving inpatient care in the South West zone.

There are 17 people in intensive care - 1 in the North West zone, 4 in the North Central zone, 6 in the Saskatoon zone, 1 in the Central East zone, and 4 in the Regina zone.

There is 1 person in intensive care in the South West zone.

To date, 884,309 COVID-19 tests have been processed in Saskatchewan.

And yesterday, 2,165 COVID-19 tests were processed.

As of June 10 there were a total of 11,504 variants of concern cases identified by screening in the province - 274 in the Far North West zone, 1 in the Far North Central zone, 74 in the Far North East zone, 715 in the North West zone, 536 in the North Central zone, 75 in the North East zone, 1,965 in the Saskatoon zone, 120 in the Central West zone, 626 in the Central East zone, 4,721 in the Regina zone, 839 in the South Central zone, and 1,103 in the South East zone.

There are 388 total variant of concern cases in the South West zone.

There are 67 screened variants of concern cases with residence pending.

No new lineage results are reported.

Of the 6,199 variants of concern cases with lineages identified by whole genome sequencing in the province, 5,932 are Alpha (B.1.1.7), 208 are Gamma (P.1), 49 are Delta (B.1.617.2), and 10 are Beta (B.1.351).

An additional 15,212 doses of COVID-19 vaccine have been given in Saskatchewan, bringing the total number administered to 860,651.

Of those 15,212 vaccine doses, there were 396 administered in the South West zone.

Seventy-eight percent of those over the age of 40, 73% of those over 30, 68% of those over 18, and 66% of those over 12 have received their first vaccine dose.

Saskatchewan has been allocated 89,880 Moderna doses for the week of  June 14, and 130,620 Moderna doses for the week of June 21.

By June 24, every eligible resident aged 12 and older will be able to receive their second vaccine shot, depending on the length of time that has passed since their first shot.

With the increased Moderna deliveries expected, the province is able to accelerate the second dose schedule for all residents with updates scheduled Mondays and Thursdays each week until all remaining populations are eligible. Timelines may change due to vaccine availability.

When all persons 12 and older become eligible to receive their second doses starting June 24, vaccinations will be provided based on the manufacturer interval. For Moderna this is 28 days after the first dose, and for Pfizer, this is 21 days after the first dose. Note that residents may receive their second doses up to four months following their first dose, but it's highly recommended that you receive your second dose as soon as you are eligible.

A limited number of first doses of AstraZeneca have been administered since May 5 to those individuals who have contraindication for mRNA vaccines. If you received AstraZeneca as recommended by your health care provider after May 5, arrangements will be made to administer your second dose based on current, recommended intervals.